Amphastar Pharmaceuticals

$22.62
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.43 (1.94%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell AMPH and other stocks, options, ETFs, and crypto commission-free!

About AMPH

Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments. Read More The Finished Pharmaceutical Products segment manufactures, markets and distributes enoxaparin, cortrosyn, amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment manufactures and distributes recombinant human insulin and porcine insulin. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

Employees
2,078
Headquarters
Rancho Cucamonga, California
Founded
1996
Market Cap
1.07B
Price-Earnings Ratio
21.29
Dividend Yield
0.00
Average Volume
249.20K
High Today
$22.63
Low Today
$22.21
Open Price
$22.32
Volume
210.28K
52 Week High
$25.43
52 Week Low
$17.71

Collections

AMPH News

ReutersAug 8

Edited Transcript of AMPH earnings conference call or presentation 7-Aug-19 9:00pm GMT

13

AMPH Earnings

-$0.05
$0.01
$0.07
$0.13
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
$0.03 per share
Actual
$0.08 per share

More AMPH News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.